Who makes clarithmycin?

clarithmycin is developed by Shahid Sadoughi University of Medical Sciences and Health Services.

What development phase is clarithmycin in?

clarithmycin is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

clarithmycin

Shahid Sadoughi University of Medical Sciences and Health Services · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	clarithmycin
Also known as	Crixan, Claritt, Clarac, Biaxin, Klaricid, Klacid...
Sponsor	Shahid Sadoughi University of Medical Sciences and Health Services
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Aizthromycin or Clarithromycin in H-pylori Eradication Regimen (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

clarithmycin CI brief — competitive landscape report
clarithmycin updates RSS · CI watch RSS
Shahid Sadoughi University of Medical Sciences and Health Services portfolio CI